Leukemia Treatment

Integrative Leukemia Care: Enhancing Standard Therapies with Whole-Person Support

While conventional therapies remain the first line of treatment for most leukemia patients, our integrative protocols offer vital options when chemotherapy fails — or when patients seek to strengthen and complement their ongoing medical care.

Integrative Leukemia Care: Enhancing Standard Therapies with Whole-Person Support

While conventional therapies remain the first line of treatment for most leukemia patients, our integrative protocols offer vital options when chemotherapy fails — or when patients seek to strengthen and complement their ongoing medical care.

A Balanced Approach to Leukemia Treatment

Leukemia, a cancer of the blood and bone marrow, often requires immediate and aggressive medical intervention. For many patients, treatments such as chemotherapy, targeted therapies, immunotherapy, or bone marrow transplantation represent the standard of care — and in many cases, the most appropriate first step.

However, not all patients respond fully to these approaches. Some experience relapse, resistance, or side effects that significantly impact quality of life. Others wish to enhance the effectiveness of chemotherapy, improve immune resilience, and better tolerate ongoing treatments.

At Oasis of Hope Cancer Center, we specialize in integrative leukemia care designed to work alongside conventional treatment or offer new options when standard therapies have not achieved the desired results.

Doctor with Orange Ribbon for Leukemia, Kidney cancer day, world Multiple Sclerosis, CRPS, Self Injury Awareness month. Healthcare and word cancer day concept

Understanding Leukemia

Main Types of Leukemia

  • Acute Lymphoblastic Leukemia (ALL): Rapidly progressing; more common in children but also affects adults.
  • Acute Myeloid Leukemia (AML): Aggressive leukemia requiring immediate treatment.
  • Chronic Lymphocytic Leukemia (CLL): Slow-growing, often managed with observation before active treatment.
  • Chronic Myeloid Leukemia (CML): Associated with the Philadelphia chromosome and typically treated with tyrosine kinase inhibitors (TKIs).

Limitations of Conventional Treatment

  • Chemotherapy resistance may develop, reducing long-term effectiveness.
  • Bone marrow or stem cell transplants are not accessible to all and carry significant risks.
  • Targeted therapies (TKIs or monoclonal antibodies) may lose efficacy over time.
  • Side effects such as immune suppression, fatigue, infections, and organ toxicity often impair recovery and quality of life.

The Oasis of Hope Approach

Our philosophy is to work with, not against, conventional medicine. For many patients, our therapies are designed to complement ongoing care, improving outcomes and overall well-being.

Supportive Integrative Care During Chemotherapy

  • Therapies to reduce side effects such as nausea, fatigue, and infection risk
  • Immune support to protect against opportunistic infections
  • Nutritional and metabolic interventions to promote resilience and recovery

Potentiation of Conventional Therapy

  • High-dose Vitamin C, curcumin, and ozone therapy to increase tumor cell sensitivity to chemotherapy
  • Metabolic therapies that disrupt cancer cell energy production, enhancing drug effectiveness

Advanced Immunotherapy – The ImPACT Program

At Oasis of Hope, leukemia patients have access to our signature ImPACT Immunotherapy Program (Immune Personalized Autologous Cell Therapy) — a next-generation immune restoration approach that uses the patient’s own immune cells to fight leukemia throughout the bloodstream and bone marrow.

Our cGMP-certified and ISO-accredited laboratory produces personalized immune cell therapies for each patient, ensuring precision, safety, and efficacy.

Adoptive Immune Cell Therapy (NK, T-Cells, and LAK Cells)

  • Natural Killer (NK) cells and Lymphokine-Activated Killer (LAK) cells are expanded into the billions and activated to improve their cancer-fighting capabilities.
  • Upon reinfusion, they circulate systemically, targeting circulating leukemia cells and diseased marrow while strengthening immune function.

Co-Activated Cell Therapy

Many leukemia patients receive Co-Activated Cell Therapy, a core component of the ImPACT Program, in which Dendritic Cells and LAK Cells are combined in one infusion.

This dual-cell strategy provides both immediate leukemia-killing activity and long-term immune memory, helping reduce relapse and maintain remission.

Hematology Oversight & Specialized Studies

Every leukemia patient at Oasis of Hope is evaluated and monitored by a board-certified hematologist. We perform specialized hematological studies — including bone marrow, immune marker, and cytokine analysis — to guide therapy design, track immune recovery, and optimize treatment response.

This close hematologic collaboration ensures that every immunotherapy and metabolic protocol is scientifically guided and precisely monitored.

Who We Treat

  • Patients beginning conventional care who want to minimize side effects and support immune function.
  • Patients in remission seeking to strengthen immunity and prevent recurrence.
  • Patients with relapsed or resistant leukemia who need new options beyond chemotherapy.
  • Patients awaiting or recovering from bone marrow transplantation requiring immune and nutritional support.

Patient Stories

(Individual results vary; we discuss realistic expectations during your consultation.)

After multiple rounds of chemotherapy for AML, my doctors told me options were limited. At Oasis of Hope, I found a program that didn’t just attack the cancer—it strengthened my body. The Oais therapy me regain strength, and I tolerated my last round of chemo better than expected. I finally feel like I have a fighting chance.

Daniel P.

,
Acute Myeloid Leukemia

FAQs:
Leukemia Treatment

Absolutely. We often work in coordination with your current specialist to ensure that our integrative therapies enhance—not interfere with—your ongoing treatment. Many patients combine our program with chemotherapy, targeted drugs, or bone marrow–supportive care.

Yes. Every leukemia patient at Oasis of Hope is evaluated in collaboration with a hematologist. We perform detailed hematological studies and blood analysis to guide therapy decisions, monitor response, and ensure that all treatments are safe and well-coordinated with your primary care team.

Yes. We treat acute and chronic leukemias, including AML, ALL, CML, and CLL, as well as treatment-resistant or relapsed cases. Each plan is personalized to your diagnosis, disease stage, and immune status.

When standard therapy loses effectiveness, our ImPACT immunotherapy program may offer new options. By retraining your immune system to recognize and attack abnormal cells, we aim to restore disease control and improve blood health.

Yes. Many patients come for immune restoration between rounds of chemo or after completing them. Our therapies help rebuild white blood cell counts, reduce fatigue, and strengthen recovery.

In addition to conventional oncology support, we offer personalized cell-based immunotherapy, metabolic therapy, and nutritional medicine to target cancer from multiple angles—biological, metabolic, and immune. We also provide emotional and spiritual care to heal the whole person.

Yes. Every protocol begins with detailed blood work to ensure safety. Our medical team adjusts doses and timing to match your immune status, helping your body recover strength rather than strain it.

Yes. Many patients experience improved energy, appetite, and immune resilience as their blood values stabilize. Our goal is not only to fight disease but to restore vitality and quality of life.

Most patients complete a 2–3 week inpatient program, followed by a home protocol that supports ongoing immune and metabolic balance. Regular follow-ups are done remotely or with your local physician

A woman with long dark hair, wearing a blue top and silver earrings, smiles at the camera. The background features greenery and horizontal wooden slats, creating a welcoming Patient Banner vibe.
A woman with short brown hair is smiling and wearing a blue shirt. She is indoors with blurred white blinds and greenery in the background, perfect for a healthcare patient banner.
A man with gray hair and beard wearing a red zip-up sweater stands in front of a blurred indoor background, resembling a welcoming image for a Patient Banner on the Become A Patient page.
A woman with short brown hair is smiling and wearing a blue shirt. She is indoors with blurred white blinds and greenery in the background, perfect for a healthcare patient banner.
A woman with long blonde hair and glasses, wearing a red patterned shirt, sits indoors in front of a white wall with green plants beside a Patient Banner.
An older woman with short gray hair and glasses, wearing a dark patterned top, is looking at the camera. The bright background features white elements and green blurred foliage, making her an ideal fit for a welcoming Become A Patient banner.

Become a Patient

Take the first step toward personalized, integrative cancer care designed around your unique needs. Connect with our team today to explore your options and begin your journey with Oasis of Hope.

An older woman with short gray hair and glasses, wearing a dark patterned top, is looking at the camera. The bright background features white elements and green blurred foliage, making her an ideal fit for a welcoming Become A Patient banner.
A woman with long blonde hair and glasses, wearing a red patterned shirt, sits indoors in front of a white wall with green plants beside a Patient Banner.
A young woman with long dark hair and glasses smiles at the camera while standing on a city street, a Patient Banner visible in the background alongside blurred cars and buildings.